Success Stories: Breakthrough Cancer Treatment Research in Nanomaterials Earns NIW Approval with NAILG’s Expertise

 

Client’s Testimonial:

“I applied for NIW (PP) and my case was approved in 10 days. This is all due to spectacular case preparation by Chen Immigration Attorney, who answered all questions clearly, provided a list of required evidence, and prepared a fantastic petition. Thank you so much.”


On February 20th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Chemistry (Approval Notice).


General Field: Chemistry

Position at the Time of Case Filing: Scientist

Country of Origin: Nepal

State of Residence at the Time of Filing: Arkansas

Approval Notice Date: February 20th, 2025

Processing Time: 14 days (Premium Processing Requested)


Case Summary:           

NAILG is proud to announce the successful approval of an EB-2 NIW petition for a highly accomplished chemistry expert whose research is transforming the field of targeted cancer therapeutics. His proposed endeavor focuses on synthesizing novel engineered nanoplatforms for therapeutic applications and non-cell culture-based efficacy determination of targeting therapeutic nanomaterials with an ultimate goal of developing cancer treatments with specificity, addressing one of the most pressing medical challenges of our time.

His work is particularly critical in the fight against the growing prevalence of cancer. By harnessing the power of nanomaterial chemistry, he is developing therapeutic strategies that not only improve treatment effectiveness but also reduce off-target effects, enhancing patient outcomes and quality of life, paving the way toward individualized cancer treatment.

The client’s impressive record at the time of filing included:

  • 11 peer-reviewed journal articles, 5 of which were first-authored, 8 conference abstracts
  • 429 citations to his published work
  • Research funding from the National Science Foundation (NSF) and the National Institutes of Health (NIH) underscores the trust and investment of leading national funding agencies in his
These achievements, combined with his unique expertise and ongoing contributions, made a compelling case for the national importance and substantial merit of his endeavor.

With NAILG’s strategic presentation of his qualifications, the petition clearly demonstrated how his research not only advances the scientific understanding of nanomaterial-based therapeutics but also delivers direct benefits to public health and the U.S. healthcare system. The NIW approval now enables him to continue driving forward innovations that promise to change the landscape of cancer treatment and provide life-saving options for countless patients.